Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Six bodies registered...

    Six bodies registered with CDSCO to audit medical device manufacturing sites as per new MD Rules

    Farhat NasimWritten by Farhat Nasim Published On 2019-08-04T15:29:42+05:30  |  Updated On 13 Aug 2021 5:00 PM IST

    New Delhi: Through a recent public notice, the apex drug regulatory body, Central Drugs Standard Control Organisation(CDSCO) has notified six bodies to carry out an audit of manufacturing site under the provisions of the Medical Devices Rules, 2017.


    In this connection, six bodies have been registered with CDSCO. These audit services providers include New Delhi-based Intertek India Pvt. Ltd which was established in the year 1997; TUV Rheinland India Pvt. Ltd located in West Wing, Electronic City in Bengaluru; TUV Sud South Asia Pvt. Ltd situated in Mumbai; Dnv GI Business Assurance India Private Limited, Mumbai; BSI Group India Pvt. Ltd, New Delhi and BSCIC Certifications Pvt Ltd situated in Faridabad.


    "The notified bodies registered with CDSCO under provisions Medical Devices Rules, 2017 to carry out an audit of manufacturing site under the provisions of said rules," reads the notice undersigned by the Joint Drugs Controller of India, Dr V G Somani.


    Also Read: Doctors should prescribe only generic medicines: CDSCO Committee


    New Medical Device (MD) Rules 2017 were notified last year and has come into effect from the beginning of 2018 onwards in the country. MD Rules 2017 under Drugs and Cosmetics (D&C) Act is meant to regulate the manufacture, import, sale and distribution of the medical devices.


    New MD Rules 2017 cover medical devices, invitro diagnostics (IVDs), disinfectants, surgical sutures, ligature, condoms, bandages etc. It sets new standards for manufacturing and use of medical devices.


    Medical Dialogues had earlier reported that to advice CDSCO on matters related to the regulation and implementation of medical devices, the Union Health Ministry had constituted a special committee under the name Medical Devices Technical Advisory Group (MDTAG), chaired by Drugs Controller General of India (DCGI) while the Deputy Drugs Controller of India, Medical Devices Division, CDSCO had been appointed as the Member Secretary.


    Also Read: 22-member Committee Constituted to guide CDSCO on Medical Device Regulation

    bandagesBSCIC CertificationsBSI Group IndiaCDSCOcondomsDCGIdisinfectantsDnv GI Business Assurance IndiaDrugs Controller General of IndiaIntertek Indiainvitro diagnosticsIVDsligatureMDTAGMedical Device Rules 2017Medical DevicesMinistry of Health and Family Welfaresurgical suturesTUV Rheinland IndiaTUV Sud South AsiaUnion Health Minister

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok